Mounjaro can be a twin GIP and GLP-1 receptor agonist, although Wegovy acts solely to the GLP-1 receptor. Mounjaro might have a more powerful effect on human body body weight, but just isn't solely accredited for weightloss. Like Wegovy, Mounjaro is injected once per week.Given that its European Union acceptance in January 2022 and subsequent launc